NCT01845467View on ClinicalTrials.gov

Efficacy of Secretin MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

February 28, 2013

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Cellular Diagnosis, Pancreatic CancerAutoimmune Pancreatitis
Trial Locations (1)

21205

Johns Hopkins Hospital, Baltimore

Sponsors

Collaborators (1)

ChiRhoClin, Inc.
All Listed Sponsors
collaborator

ChiRhoClin, Inc.

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT01845467 - Efficacy of Secretin MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis | Biotech Hunter | Biotech Hunter